跳至主要内容
临床试验/NCT04644380
NCT04644380已完成不适用

Assessment of the INVOcell Culture Device When Used for up to Five-Day Incubation

INVO Bioscience, Inc.2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2020年12月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
2
主要终点
Device Retention

研究概览

简要总结

The INVOcell Culture Device received de novo request for 3-day intravaginal incubation. The device is held in place with the intravaginal cavity by a Retention Device. The clinical study will assess the ability of a modified Retention Device to hold INVOcell in place during 5-day vaginal incubation as well as comfort and vaginal irritation as secondary endpoints.

详细描述

This is a single center, open label non-comparative prospective trial to evaluate the retention of the INVOcell IVC with the Retention Device over the vaginal incubation period of up to 5 days.

The purpose of this study is to assess the retention of the INVOcell IVC device with the Retention Device over the vaginal incubation period of up to 5 days.

Primary Endpoint

• Retention of the INVOcell IVC device with the Retention Device over the vaginal incubation period of up to 5 days.

Secondary Endpoint

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 42 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Have been informed about the study and have given their written consent.
  • Patients 18 years to 42 years
  • Women who are scheduled for an oocyte retrieval in anticipation of INVOcell IVF.

排除标准

  • Inability to read and speak English fluently
  • Identified vaginal infection
  • Recent pelvic surgery based on clinical history and physical examination.
  • History of toxic shock syndrome
  • Inability to tolerate the placement or wearing of the INVOcell IVC or INVOcell Retention Device.
  • Inability to tolerate a speculum examination
  • Unwilling or unable to wear the INVO Retention (diaphragm) during the incubation.
  • Unable or unwilling to sign informed consent or abide by study follow up assessment requirements.

结局指标

主要结局

Device Retention

时间窗: 5 days

The primary endpoint is INVOcell IVC retention with the Retention Device. The following will be assessed: Whether the INVOcell IVC stays in place (is retained within the vaginal cavity) while being used with the Retention Device during 5 days of continuous vaginal incubation.

次要结局

  • Optical clarity(5 days)
  • Comfort(5 days)
  • Vaginal tissue reactions(5 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Assessment of the INVOcell Culture Device When Used... | 临床试验